Works matching IS 15505952 AND DT 2009 AND VI 6 AND IP 3
Results: 29
The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I--statistics and the case for the 'greater good'.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Borderline personality symptomatology, casual sexual relationships, and promiscuity.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Clozapine-induced bowel infarction: a case report.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Dissociative identity disorder: a controversial diagnosis.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Using nonevidence-based approaches to treat patients with Alzheimer's disease.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Treatment of schizoaffective disorder.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
USPTO issues notice of final determination for patent term extension for Namenda.
- Published in:
- 2009
- Publication type:
- Journal Article
Cipher receives tentative FDA approval for extended-release tramadol capsules.
- Published in:
- 2009
- Publication type:
- Journal Article
Schering-Plough submits response to FDA for SAPHRIS (asenapine) in the acute treatment of both schizophrenia and bipolar I disorder.
- Published in:
- 2009
- Publication type:
- Journal Article
Sepracor reports preliminary phase II study results for Sep-225441 for the treatment of generalized anxiety disorder.
- Published in:
- 2009
- Publication type:
- Journal Article
Sen. Grassley: it should be legal to buy prescription drugs from other countries.
- Published in:
- 2009
- Publication type:
- Journal Article
AstraZeneca receives FDA complete response letter on SEROQUEL XR for generalized anxiety disorder.
- Published in:
- 2009
- Publication type:
- Journal Article
New guidelines for prescribing opioid pain drugs published.
- Published in:
- 2009
- Publication type:
- Journal Article
Editor's message: issue highlights, March 2009.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Journal Watch.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 44
- By:
- Publication type:
- Article
THE USE OF PLACEBO-CONTROLLED CLINICAL TRIALS FOR THE APPROVAL OF PSYCHIATRIC DRUGS: Part I-Statistics and the Case for the "Greater Good".
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 41
- By:
- Publication type:
- Article
Borderline Personality Symptomatology, Casual Sexual Relationships, and Promiscuity.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 36
- By:
- Publication type:
- Article
Clozapine-induced Bowel Infarction: A Case Report.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 30
- By:
- Publication type:
- Article
SEPRACOR REPORTS PRELIMINARY PHASE II STUDY RESULTS FOR SEP-225441 FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 13
- Publication type:
- Article
Dissociative Identity Disorder: A Controversial Diagnosis.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 24
- By:
- Publication type:
- Article
Treatment of Schizoaffective Disorder.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 15
- By:
- Publication type:
- Article
USPTO ISSUES NOTICE OF FINAL DETERMINATION FOR PATENT TERM EXTENSION FOR NAMENDA.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 14
- Publication type:
- Article
CIPHER RECEIVES TENTATIVE FDA APPROVAL FOR EXTENDED-RELEASE TRAMADOL CAPSULES.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 14
- Publication type:
- Article
Editor's Message.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 4
- By:
- Publication type:
- Article
Using Nonevidence-based Approaches to Treat Patients with Alzheimer's Disease.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 18
- By:
- Publication type:
- Article
SEN. GRASSLEY: IT SHOULD BE LEGAL TO BUY PRESCRIPTION DRUGS FROM OTHER COUNTRIES.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 12
- Publication type:
- Article
ASTRAZENECA RECEIVES FDA COMPLETE RESPONSE LETTER ON SEROQUEL XR FOR GENERALIZED ANXIETY DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 12
- Publication type:
- Article
NEWGUIDEUNESFOR PRESCRIBING OPIOID PAIN DRUGS PUBLISHED.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 12
- Publication type:
- Article
SCHERING-PLOUGH SUBMITS RESPONSE TO FDA FOR SAPHRIS (ASENAPINE) IN THE ACUTE TREATMENT OF BOTH SCHIZOPHRENIA AND BIPOLAR I DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 13
- Publication type:
- Article